Potential Role of the Quality Assurance Review Center Platform in Global Radiation Oncology

The 2014 World Health Organization (WHO) Cancer Report describes an alarming growth in the cancer burden worldwide and underscores that, of the 14 million new cases of cancer and 8.2 million cancer-related deaths per year, 60% and 70%, respectively, occur in low-income and middle-income countries (LMICs) (1). These countries are the least capable of dealing with cancer without some form of collaboration. The disparities in cancer-related deaths in part reflect poignant underlying inequalities in access to radiation oncology services; also, a majority of the population groups that experience disparities is significantly underrepresented in cancer clinical trials (2).

http://ift.tt/2ztyEJu